Core Insights - CareCloud resumed dividends on preferred shares in 2025 and plans to pay double dividends on Series B preferred stock starting in 2026 to address arrearages [1] - The company converted approximately 80% of Series A preferred shares into common stock in 2025, eliminating over $7 million in annual dividend obligations [1] Financial Performance - Non-GAAP free cash flow was $20.5 million in 2025, a 55% increase from $13.2 million in 2024, indicating improved financial flexibility [2] - GAAP operating cash flow reached $28.6 million in 2025, up 38% year over year, with $8.7 million generated in Q4, a 66% increase [3] - Adjusted EBITDA for the full year was $27.5 million, representing a 23% margin, and increased 15% from $24.1 million in 2024 [4] - GAAP net income for 2025 was $10.8 million, up over 37% year over year, marking the first full year of positive EPS since the 2014 IPO [6] Revenue Growth - Full-year revenue for 2025 was $120.5 million, up nearly 9% year over year, with Q4 revenue at $34.4 million, a nearly 22% increase from the prior year [7] - CareCloud raised revenue guidance twice in 2025 and exceeded its final target [7] Strategic Acquisitions - CareCloud completed multiple acquisitions in 2025, funded entirely through free cash flow, resulting in no common shareholder dilution [10] - The acquisition of Medsphere Systems expanded CareCloud's reach into the inpatient hospital market and added new software products [11] - The fourth-quarter revenue included approximately $7.2 million related to the Medsphere acquisition [12] AI Initiatives - CareCloud launched an AI Center of Excellence in April 2025, focusing on integrating AI solutions into healthcare workflows [14] - The flagship AI product, stratusAI Desk Agent, was fully released in December 2025, handling various administrative tasks [15] - AI tools are being utilized to improve revenue cycle management operations, aiming for "zero touch claims" with minimal human intervention [17] 2026 Guidance - For 2026, CareCloud guided revenue of $128 million to $130 million and adjusted EBITDA of $29 million to $31 million, reflecting margin expansion [19] - GAAP EPS is expected to be between $0.20 and $0.23, representing an increase of over 100% from 2025 [19] Market Position - CareCloud's healthcare IT solutions are supported by over 25 years of proprietary data, providing a competitive advantage in the industry [21] - The company serves small to mid-size physician groups and specialty clinics across the United States, enhancing operational efficiency through its cloud-based platform [23][24]

Financial Data and Key Metrics Changes - For the full year 2025, the company generated revenue of $120.5 million, representing nearly 9% year-over-year growth [7] - In Q4 2025, revenue reached $34.4 million, up nearly 22% year-over-year, indicating accelerating momentum [7] - GAAP net income for 2025 was $10.8 million, a year-over-year increase of more than 37%, with earnings per share of $0.10 [7] - Adjusted EBITDA expanded to $27.5 million with a 23% margin, up more than 14% year-over-year [8] - Free cash flow for 2025 reached approximately $20.5 million, compared to $13.2 million in 2024, representing growth of more than 500% from 2023 [8] Business Line Data and Key Metrics Changes - The company completed multiple acquisitions in 2025, including Medsphere Systems, which expanded its capabilities into the inpatient hospital market [10] - The integration of AI tools into the platform has already resulted in new customer wins under the CareCloud umbrella [11] - The company aims to penetrate newly acquired health system customers with its RCM and AI products as part of its 2026 growth strategy [12] Market Data and Key Metrics Changes - The healthcare technology market is at an inflection point, with AI adoption moving from pilot programs to production deployment [12] - The company recognizes a multi-billion-dollar addressable opportunity in the U.S. for its AI front desk assistant [12] Company Strategy and Development Direction - The company’s 2026 growth strategy focuses on leveraging its dual platform footprint in ambulatory and inpatient markets to drive organic growth and acquisition synergies [13] - Strategic acquisitions have been a cornerstone of growth, with a disciplined approach to acquiring companies at attractive valuations [14] - The company plans to remain active in M&A in 2026 and beyond, identifying complementary targets that can benefit from its AI capabilities [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue guidance of $128 million to $130 million for 2026, with adjusted EBITDA of $29 million to $31 million [15] - The company anticipates GAAP EPS of $0.20 to $0.23 per share, representing an increase of more than 100% over 2025 [15] - Management highlighted the importance of disciplined execution, innovation, and creating long-term value for stakeholders [35] Other Important Information - The company resumed dividends on its preferred shares at the beginning of 2025 and plans to pay double dividends on Series B preferred stock starting in 2026 [9] - The conversion of approximately 80% of Series A preferred shares into common eliminated more than $7 million in annual dividend obligations [9] Q&A Session Summary Question: Can you expand on how you're planning on monetizing AI in 2026? - Management discussed the favorable M&A environment and the strategy to integrate AI capabilities into acquired platforms, enhancing their attractiveness and market position [38][41] Question: What was behind the recent contract wins with new customers? - Management noted the expansion of the sales and marketing team and the focus on cross-selling and upselling existing customers, particularly those acquired through recent transactions [45][46] Question: How should investors think about CareCloud's exposure to AI disruption? - Management emphasized that the company operates in a niche healthcare IT space with deep industry moats, making it less vulnerable to generic AI disruptions [54][56] Question: What are the focuses for the use of excess cash flow? - Management indicated that the focus would be on acquisitions, enhancing the capital structure, and investing in AI development [73] Question: Who are the company's main competitors? - Management identified competitors in the EHR space such as eClinicalWorks and athenahealth, and noted that the AI competitive landscape is broader, with some players lacking a vertical approach [75][78]

Financial Data and Key Metrics Changes - For the full year 2025, the company generated revenue of $120.5 million, representing nearly 9% year-over-year growth [7] - In Q4 2025, revenue reached $34.4 million, up nearly 22% year-over-year, indicating accelerating momentum [7] - GAAP net income for 2025 was $10.8 million, a year-over-year increase of more than 37%, with earnings per share of $0.10 [7] - Adjusted EBITDA expanded to $27.5 million with a 23% margin, up more than 14% year-over-year [8] - Free cash flow reached approximately $20.5 million for 2025, compared to $13.2 million in 2024, representing growth of more than 500% from 2023 [8] Business Line Data and Key Metrics Changes - The company completed multiple acquisitions in 2025, including Medsphere Systems, which expanded its capabilities into the inpatient hospital market [10] - The integration of AI tools into the platform has already resulted in new customer wins under the CareCloud umbrella [11] - The company aims to penetrate newly acquired health system customers with its RCM and AI products as part of its 2026 growth strategy [12] Market Data and Key Metrics Changes - The healthcare technology market is at an inflection point, with AI adoption moving from pilot programs to production deployment [12] - The company recognizes a multi-billion-dollar addressable opportunity in the U.S. for its AI front desk assistant [12] Company Strategy and Development Direction - The company’s 2026 growth strategy focuses on leveraging its dual platform footprint in ambulatory and inpatient markets to drive organic growth and acquisition synergies [13] - Strategic acquisitions have been a cornerstone of growth, with a disciplined approach to acquiring companies at attractive valuations [14] - The company plans to remain active in M&A in 2026 and beyond, identifying complementary targets that can benefit from its AI capabilities [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue guidance of $128 million-$130 million for 2026, with adjusted EBITDA of $29 million-$31 million [15] - The company anticipates GAAP EPS of $0.20-$0.23 per share, representing an increase of more than 100% over 2025 [15] - Management highlighted the importance of disciplined execution and innovation to create long-term value for stakeholders [35] Other Important Information - The company resumed dividends on its preferred shares at the beginning of 2025 and plans to pay double dividends on Series B preferred stock starting in 2026 [9] - The conversion of approximately 80% of Series A preferred shares into common eliminated more than $7 million in annual dividend obligations [9] Q&A Session Summary Question: Can you expand on how you're planning on monetizing AI in 2026? - Management discussed the favorable M&A environment and the strategy to integrate AI capabilities into acquired platforms to enhance their attractiveness and market position [38][41] Question: What was behind the recent contract wins and future opportunities? - Management noted the expansion of the sales team and the focus on cross-selling additional services to existing clients acquired through recent transactions [45][46] Question: How does CareCloud's exposure to AI disruption compare to being an AI beneficiary? - Management emphasized that CareCloud operates in a niche healthcare IT space with deep industry moats, making it less vulnerable to generic AI disruptions [54][56] Question: What are the focuses for the use of excess cash flow? - Management indicated that the focus would be on acquisitions, enhancing capital structure, and investing in AI development [73] Question: Who are CareCloud's main competitors? - Management identified competitors in the EHR space such as eClinicalWorks and athenahealth, and noted that the AI competitive landscape varies depending on the product [75][76]

Financial Data and Key Metrics Changes - For the full year 2025, the company generated revenue of $120.5 million, representing nearly 9% year-over-year growth, with Q4 revenue of $34.4 million, up nearly 22% year-over-year [6][32] - GAAP net income for 2025 was $10.8 million, a year-over-year increase of more than 37%, with earnings per share of $0.10, marking the first full year of positive EPS since the 2014 IPO [6][31] - Adjusted EBITDA expanded to $27.5 million with a 23% margin, up more than 14% year-over-year [7][33] - Free cash flow reached approximately $20.5 million for 2025, compared to $13.2 million in 2024, representing growth of more than 500% from 2023 [7][34] Business Line Data and Key Metrics Changes - The company completed multiple acquisitions in 2025, including Medsphere Systems, which expanded its capabilities into the inpatient hospital market [9][10] - Revenue related to the Medsphere acquisition in Q4 was approximately $7.2 million [32] Market Data and Key Metrics Changes - The healthcare technology market is at an inflection point, with AI adoption moving from pilot programs to production deployment, creating a multi-billion-dollar addressable opportunity in the U.S. [11][12] - The company aims to leverage its dual platform footprint in ambulatory and inpatient markets to drive organic growth and acquisition synergies [12] Company Strategy and Development Direction - The 2026 growth strategy focuses on penetrating newly acquired health system customers with RCM and AI products, emphasizing operating leverage from strategic investments [11][14] - The company plans to remain active in M&A in 2026 and beyond, identifying complementary targets that can benefit from its AI capabilities [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue guidance of $128 million-$130 million for 2026, with adjusted EBITDA of $29 million-$31 million and GAAP EPS of $0.20-$0.23 per share, representing over 100% growth from 2025 [14][15] - The company highlighted its strong financial position, with zero drawn on its credit line and a focus on disciplined execution and innovation [15][34] Other Important Information - The company resumed dividends on preferred shares in early 2025 and began paying double dividends on Series B preferred stock starting in 2026 [8][31] - The AI Center of Excellence was launched in April 2025, focusing on building AI solutions that create measurable impact for healthcare providers [17][18] Q&A Session Summary Question: Can you expand on how you're planning on monetizing AI in 2026? - Management discussed the favorable M&A environment and the strategy to integrate AI capabilities into acquired platforms, enhancing their attractiveness and market position [39][41] Question: What was behind the recent contract wins and future opportunities? - The company has expanded its sales and marketing team, focusing on cross-selling and upselling to existing customers acquired through recent transactions [45][46] Question: How should investors think about CareCloud's exposure to AI disruption? - Management emphasized that CareCloud operates in a niche healthcare IT market with deep industry moats, making it less vulnerable to generic AI disruptions [54][55] Question: What are the focuses for the use of excess cash flow? - The company aims to use excess cash flow for acquisitions, enhancing capital structure, and investing in AI development [73][74] Question: Who are CareCloud's main competitors? - Competitors include eClinicalWorks, AdvancedMD, and athenahealth in the EHR space, with a wider field in AI solutions [75][76]

Q4 2025 RESULTS Nasdaq Global Market: CCLD, CCLDO March 12, 2026 A leading provider of technology-enabled services and AI-based solutions that redefine the healthcare revenue cycle © CareCloud, Inc. 2026 Safe Harbor Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by te ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2026 CARECLOUD, INC. (Exact name of registrant as specified in its charter) Delaware 001-36529 22-3832302 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 7 Clyde Road, Somerset, New Jersey, 08873 (Address of principal executive ...

Core Insights - CareCloud, Inc. reported strong financial results for the full year and fourth quarter ended December 31, 2025, exceeding revenue guidance and achieving its first full-year positive GAAP EPS since its IPO in 2014 [1][4]. Financial Highlights - Full-year revenue reached $120.5 million, an increase of 8.7% from $110.8 million in FY 2024 [2]. - Fourth-quarter revenue was $34.4 million, up 21.9% from $28.2 million in Q4 2024 [2]. - GAAP net income for FY 2025 was $10.8 million, a 37.5% increase from $7.9 million in FY 2024 [2]. - GAAP EPS for FY 2025 was $0.10, compared to a loss of $0.28 in FY 2024, marking a significant turnaround [2]. - Adjusted EBITDA for FY 2025 was $27.5 million, up 14.5% from $24.1 million in FY 2024 [2]. Strategic Developments - CareCloud entered the inpatient software market through strategic acquisitions, expanding its product portfolio to include inpatient EHR, RCM, analytics, and a top-ranked EDIS platform [5]. - The company launched AI products, including stratusAI Desk Agent, which automates approximately 75% of inbound calls, enhancing operational efficiency [5][6]. - CareCloud fully repaid $9.3 million on its line of credit by year-end, demonstrating strong cash flow generation [5]. Management Commentary - The CEO highlighted that 2025 was a transformative year, with the company proving its business model and achieving significant milestones in revenue and profitability [4]. - The Chief Strategy Officer emphasized the integration of AI and acquisition strategies as a unified growth engine, enhancing the value of acquired platforms [4]. 2026 Outlook - CareCloud projects revenue for FY 2026 to be between $128 million and $132 million, representing a growth of approximately 6-10% over FY 2025 [7]. - Adjusted EBITDA guidance for FY 2026 is set at $29 million to $31 million, indicating a growth of 5-13% from FY 2025 [7]. - GAAP EPS guidance for FY 2026 is expected to be between $0.20 and $0.23, reflecting a 100-130% increase from FY 2025 [7].

CareCloud Driving the Future of Healthcare with AI Solutions Nasdaq Global Market : CCLD, CCLDO Safe Harbor Statements 01 ™ This presentation contains for ward-lection stother he measing of the featand securifies laws. The feast storners sedde to anhiappled foluce events, folu re results of o some coses, vou canidentify fornund-lobling stolenents by termindopr such os "myx" "misht" "will" "shol." "should" "intends" "expects," "price.s" "pricipants:" "policions" "forecasts," "predicts," "possible," "potentia ...

Core Viewpoint - CareCloud, Inc. will announce its financial results for Q4 and the full year of 2025 on March 12, 2026, before market opening, followed by a conference call for investors at 8:30 a.m. Eastern Time [1]. Financial Results Announcement - The financial results will cover the fourth quarter and the full year ended December 31, 2025 [1]. - A live webcast of the conference call and related presentation slides will be available at ir.carecloud.com/events [2]. - An audio-only option for the conference call can be accessed by dialing 201-389-0920 and referencing "CareCloud, Inc. Fourth Quarter 2025 Results Conference Call" [2]. Conference Call Replay - A replay of the conference call and related presentation slides will be available approximately three hours after the call concludes at the same link [3]. - An audio-only option for the replay can be accessed by dialing 412-317-6671 and providing the access code 13758591 [3]. Company Overview - CareCloud specializes in AI-powered healthcare technology and revenue cycle management solutions, serving over 45,000 providers [4]. - The company's solutions aim to enhance financial and operational performance, streamline clinical workflows, and improve patient experience [4]. - CareCloud offers a range of products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM), and digital health [4].

Core Insights - CareCloud, Inc. has signed an agreement with Memorial Hospital in Marysville, Ohio to implement its HealthLine supply chain management platform, enhancing operational excellence and resource stewardship in community healthcare [1][2] Company Overview - CareCloud is a leader in healthcare technology and AI-powered solutions, focusing on improving financial and operational performance for healthcare providers [9] - The company’s product portfolio includes AI-driven ambulatory, revenue cycle management (RCM), and analytics offerings, with the HealthLine platform being a significant addition following the acquisition of Medsphere in August 2025 [2][9] HealthLine Platform Features - HealthLine provides real-time visibility and control over clinical supply operations, addressing critical operational priorities such as reducing supply waste, improving charge capture accuracy, and freeing clinical staff from manual inventory management tasks [3][4] - The platform is designed to enhance healthcare supply chain management by integrating clinical supply use with financial performance, thereby reducing administrative burdens on clinical staff [5][7] - Key features of HealthLine include point-of-use simplicity, automated charge capture, superior customization, mobility solutions, specialized capabilities for high-complexity areas, and modern architecture [6] Market Context - Healthcare supply chain management has become a strategic priority as organizations face rising supply costs and regulatory requirements for charge capture accuracy, necessitating modern, integrated supply chain platforms [5] - The increasing complexity of healthcare supply chains demands transparency and efficiency, which HealthLine aims to provide [3][4]